GlassScriptPhysician profile
Amy M Deeley
NPI 1215911219
$2,753.03
in general payments reported to CMS, 2019-2025
31 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $290 · 2021: $491 · 2022: $681 · 2023: $331 · 2024: $259 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $869.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $869.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $911.85 | 2019-2023 | Lo Loestrin Fe, Liletta, Orilissa |
| Amgen INC. | $292.51 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $160.32 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $152.19 | 2021-2023 | |
| Penumbra, INC. | $130.13 | 2025 | Ruby Coil |
| Exeltis, USA INC. | $99.97 | 2020-2025 | Slynd |
| Astellas Pharma US INC | $92.20 | 2022-2025 | Veozah |
| Mylan Pharmaceuticals INC. | $91.08 | 2021-2022 | |
| Hologic Sales and Service, LLC | $84.45 | 2019-2024 | Acessa Provu System, Novasure, Aptima |
| Pfizer INC. | $75.69 | 2019-2023 | |
| Myovant Sciences INC. | $69.71 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $61.01 | 2020-2023 | |
| Coopersurgical, INC. | $49.32 | 2019-2025 | Paragard T 380a |
| Allergan, INC. | $44.98 | 2019 | |
| Agile Therapeutics, INC. | $44.00 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $43.36 | 2022-2024 | Gardasil 9, Gardasil |
| Exact Sciences Corporation | $41.49 | 2023-2025 | Cologuard Collection Kit |
| Avion Pharmaceuticals | $36.42 | 2020 | |
| Ascend Therapeutics US, LLC | $30.72 | 2020-2023 | |
| Organon LLC | $29.81 | 2022-2024 | |
| Radius Health, INC. | $27.51 | 2019-2021 | |
| Therapeuticsmd, INC. | $25.72 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $23.54 | 2019 | |
| Almatica Pharma LLC | $22.24 | 2024 | Loreev Xr |
| Virtus Pharmaceuticals LLC | $19.23 | 2021 | |
| Biogen, INC. | $18.32 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $17.85 | 2022 | |
| Vertical Pharmaceuticals, LLC | $15.70 | 2019 | |
| Smith+Nephew, INC. | $15.00 | 2025 | Pico 14, Pico 7 |
| Ibsa Pharma INC. | $14.95 | 2023 | Tirosint, Licart |
| Scynexis, INC. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Deeley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.